Vaccinating Pregnant Individuals
Guidance and procedures from the American College of Obstetricians and Gynecologists (ACOG) about the COVID-19 vaccine for pregnant and lactating individuals.
Topic: Reproductive Health
Birth Control Methods
Information on birth control methods and Family PACT coverage for current and prospective Family PACT clients.
Clinical Practice Alert: Emergency Contraception
An overview of and frequently asked questions about emergency contraception (EC). EC represents a “last chance” to prevent unintended pregnancy. Categories of EC are emergency contraceptive pills (ECPs), including ulipristal acetate (UPA) and levonorgestrel (LNG) and the copper intrauterine device (IUD).
Holding an IUD birth control copper coil device in hand, used for contraception –
Clinical Practice Alert: Chlamydia and Gonorrhea Screening and Treatment
Key recommendations for chlamydia and gonorrhea screening and treatment for individuals assigned female at birth.
Clinical Practice Alert: Cervical Cancer Screening
Key recommendations for cervical cancer screening from the American College of Obstetricians and Gynecologists (ACOG) and the multidisciplinary partnership of the American Cancer Society, the American Society for Colposcopy and Cervical Pathology (ASCCP), and the American Society for Clinical Pathology.
Providing Family PACT Services During COVID-19 Part 2: Understanding Benefit Changes
September 17, 2020
The ongoing COVID-19 public health emergency has caused a shift from providing exclusively in-person services to a combination of remote and in-person visits, referred to as “hybrid visits”. This webinar will provide an update of how Family PACT services (client encounters) have changed since March, 2020.
The following topics are covered in detail:
- Medi-Cal/Family PACT policy for telephonic-only remote visits.
- A series of case studies including contraceptive visits, evaluation of genital tract infections, well person visits, and a colposcopy visit, with an emphasis on coding and billing Family PACT.
Presenters:
Resources
Implementing the 2019 ASCCP Risk-Based Management Guidelines for Abnormal Cervical Cancer Screening Tests in Your Practice
July 23, 2020
The long-awaited new ASCCP Management Guideline App is now available, as well as the print version of the 2019 Guidelines. The new guidelines are streamlined for ease of use and can be significantly more individualized than the 2012 guidance by integrating information about an individual’s previous screening test and biopsy results, and personal factors such as age and immunosuppression. The guidelines now provide recommended follow up for all 3 available cervical screening strategies.
The following topics are covered in detail:
- The rationale used in developing the Guidelines
- How various abnormalities should be managed
- Interactive demonstrations of how to use the app
- Specific considerations for the application of Family PACT benefits, including coding and billing
Learning objectives: At the end of this session, the learner will be able to:
- Describe the risk-based paradigm for managing abnormal cervical cancer screening test results.
- Explain how risk-thresholds guide the clinical actions of immediate treatment, colposcopy, and short-interval follow up.
- Demonstrate use of the ASCCP app to apply the new guidelines to patient care.
Presenters:
Resources
Providing Family PACT Services During COVID-19 Part 1: Clinical Considerations
May 8, 2020
Since March 2020, most providers of family planning services in California have shifted patient care from in-person visits to remote visits. This webinar will be conducted in a “frequently asked questions” format, focusing on the adaptations that clinicians should make in order to successfully provide family planning care remotely during the public health emergency and afterward.
The following topics are covered in detail:
- Subjects will include the role of blood pressure measurement before prescribing combined hormonal contraception
- The use of injectable birth control subcutaneous depot medroxyprogesterone acetate (DMPA-SQ)
- Syndromic treatment of sexually transmitted infections
- Pregnancy testing without a clinic visit.
- Recently enacted Family PACT and Medi-Cal policies regarding telehealth visits and remote enrollment of clients into the Family PACT program.
Presenters:
Resources
Clinical Practice Alert: Cervical Cancer Screening and Emergency Contraception
March 24, 2020
This webinar features two new Family PACT Clinical Practice Alerts.
Cervical Cancer Screening
Topics in this portion of the webinar will include benefits through Family PACT that have been expanded to include high-risk HPV-alone screening, use of this test, alternative cervical cancer screening options, and new guidelines regarding cervical cancer screening for females who are HIV positive or who are immunocompromised.
Emergency Contraception
Topics in this portion of the webinar will include the relationship between body weight and emergency contraception failure rates, when oral contraceptives can be started with females who have used ulipristal acetate, options for accessing emergency contraceptive pills and the use of the copper IUD as emergency contraception.
Presenters:
Resources:
Clinical Practice Alert: Chlamydia and Gonorrhea Screening and Treatment
June 20, 2019
Rates of sexually-transmitted diseases (STDs) such as chlamydia trachomatis (CT) and gonorrhea (GC) have reached an all-time high. In the U.S., California leads the nation in reported cases of these STDs. Because persons with CT and GC are often asymptomatic, screening is essential for the early detection and treatment that can prevent reproductive complications including pelvic inflammatory disease (PID), tubal infertility, ectopic pregnancy, and chronic pelvic pain in females and epididymitis in males.
This webinar covers current clinical guidelines for routine and targeted screening, treatment, follow-up, and prevention of CT and GC.
Learning objectives:
- Understand current guidelines for screening for CT and GC among sexually active women and men
- List the indications for anorectal and oropharyngeal CT/GC screening
- Explain when test-of-cure is indicated
- Identify the proper ICD-10 codes for lab requests and billing information
Presenters:
Resources:
